September 30, 2016 2:28 PM ET


Company Overview of Noven Pharmaceuticals, Inc.

Company Overview

Noven Pharmaceuticals, Inc. engages in the research, development, manufacture, marketing, and sale of prescription pharmaceutical products in the United States. The company’s products focus on women’s health, as well as central nervous system disorders, including attention deficit hyperactivity disorder (ADHD). Its products include Brisdelle, a non-hormonal therapy for vasomotor symptoms associated with menopause; Minivelle, an estrogen therapy patch for the treatment of vasomotor symptoms due to menopause and prevention of post-menopausal osteoporosis; CombiPatch, an estradiol/norethindrone acetate transdermal system to treat symptoms of hot flashes, and vaginal dryness associated with meno...

11960 SW 144th Street

Miami, FL 33186

United States

Founded in 1987

610 Employees





Key Executives for Noven Pharmaceuticals, Inc.

Chief Executive Officer and Director
Chief Financial Officer, Vice President and Treasurer
Vice President of Operations
Chief Medical Officer and Executive Vice President of Product Development
Age: 61
Vice President, General Counsel and Corporate Secretary
Compensation as of Fiscal Year 2016.

Noven Pharmaceuticals, Inc. Key Developments

Noven Pharmaceuticals, Inc. Appoints Jeff Mihm to Board of Directors

Noven Pharmaceuticals, Inc. has announced the appointment of Jeff Mihm to its board of directors. Mr. Mihm, who currently serves as Noven's CEO, brings extensive industry and business experience to the new, expanded role. Prior to his appointment as Noven's CEO in January 2016, Mr. Mihm most recently served as Noven's vice president, Chief Administrative Officer & General Counsel, where he oversaw Business Development, Corporate Affairs, Human Resources, Information Technology and Legal/Compliance functions. Prior to joining Noven in 2003, Mr. Mihm was a corporate attorney for more than 10 years, including as a partner in a national law firm.

Noven Pharmaceuticals, Inc. Reaches Agreement with Sebela International Limited to Assign Rights of Approval for Manufacture, Commercialization and Associated Intellectual Property for Brisdelle Capsules and Pexeva Tablets

Hisamitsu Pharmaceutical Co., Inc. announced that its wholly owned subsidiary in the United States, Noven Pharmaceuticals, Inc. has reached agreement with Sebela International Limited to assign rights of approval for manufacture, commercialization and associated intellectual property for Brisdelle (Paroxetine) Capsules, 7.5 mg and Pexeva (Paroxetine Mesylate) Tablets to Sebela.

Noven Pharmaceuticals, Inc. Announces Executive Changes

Noven Pharmaceuticals, Inc. announced the appointment of Dolores Calicchio as the company's new Vice President of Human Resources, succeeding Lance Williams, who will be retiring in April. In this role, Calicchio will lead and be responsible for all human resources activities impacting Noven's workforce across the U.S. Prior to joining Noven, Calicchio served as the Vice President of Human Resources at Carnival Cruise Lines. As Noven's Vice President of Human Resources, Calicchio will report directly to Noven's Chief Executive Officer, Jeff Mihm. Regarding Calicchio's appointment.

Similar Private Companies By Industry

Company Name Region
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States
7 Oaks Pharmaceutical Corp. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Noven Pharmaceuticals, Inc., please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at